Journavx (suzetrigine) — Point32Health
Moderate to severe acute pain
Initial criteria
- Patient age ≥ 18 years
- Patient is experiencing a new episode of moderate to severe acute pain
- Medication will not be used for longer than 14 days for any one acute pain occurrence
- Dosing frequency limited to twice daily
- Medication is not used in combination with opioid products (e.g., oxycodone, hydrocodone, codeine)
- Quantity requested does not exceed 60 tablets within the past 90 days
Approval duration
14 days (not to exceed 60 tablets/90 days)